Close Menu

Waters

NEW YORK (GenomeWeb News) – A German court has ruled in favor of Agilent Technologies in a patent infringement case against Waters dating back to 2005, Waters disclosed in its Form 10-K.

Waters this week introduced a number of new products for protein and glycan analysis, including its new Acquity UPLC CSH130 C18 columns, its XSelect HPLC CSH130 C18 columns, and three GlycoWorks kits for glycan labeling and sampl

NEW YORK (GenomeWeb News) – Waters today said that fourth-quarter revenues were essentially flat year over year as the firm missed analyst estimates on the top line but beat it on the bottom line.

Executives from several major mass spec vendors presented this week at the JP Morgan Healthcare Conference in San Francisco, offering comments on their company's recent performances and glimpses into their plans moving into 2013.

SAN FRANCISCO (GenomeWeb News) – The 31st Annual JP Morgan Healthcare Conference kicked off here yesterday with several life science tools and diagnostic firms making presentations to investors and other attendees.

Researchers at the Lawrence Berkeley National Laboratory have launched a company, Newomics, to commercialize their lab's multinozzle emitter array, or MEA, chip technology.

NEW YORK (GenomeWeb News) – Leerink Swann downgraded Waters today to Market Perform, saying the company could be challenged by the macroeconomic environment and softer end-markets, as well as increasing competition for its products and services.

Rutgers University said this week that Stephen Burley will be director of the Rutgers Center for Integrative Proteomics Research. He will assume the role in January, taking over for interim director Helen Berman.

NEW YORK (GenomeWeb News) – Roche said this week that it will invest CHF 240 million ($258.4 million) in a new diagnostics center at its Penzberg, Germany biotech center near Munich.

Austrian pharma firm Apeiron Biologics this week launched Attoquant Diagnostics, a subsidiary founded to commercialize and develop the company's RAS-Fingerprint peptide analytics service.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.